5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18254154 | C-TERMINUS MODIFIED HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN AND USE THEREOF | FOLEY, SHANON A | 1671 | Non-Final OA | May 23, 2023 |
| 18254157 | C-TERMINALLY MODIFIED HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN AND USE THEREOF | JADHAO, SAMADHAN JAISING | 1672 | Non-Final OA | May 23, 2023 |
| 17627805 | ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF | JONES, DAMERON LEVEST | 1618 | Non-Final OA | Jan 17, 2022 |
| 17619108 | HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF | MIANO, JOSEPH PAUL | 1631 | Final Rejection | Dec 14, 2021 |
| 17289848 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Nov 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial